Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation

Lignende værker

• TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
  af: Haderski, Gary J., et al.
  Udgivet: (2020)
• Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice
  af: Kojouharov, Bojidar M., et al.
  Udgivet: (2014)
• The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
  af: Krivokrysenko, Vadim I., et al.
  Udgivet: (2015)
• Toll-like Receptor 5 Agonist Protects Mice from Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head and Neck Cancer Radiotherapy
  af: Burdelya, Lyudmila G., et al.
  Udgivet: (2011)
• A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications
  af: Mett, Vadim, et al.
  Udgivet: (2021)